Showing results (1-10 of 149) with videos related to
Sort By:
Pageof 15
Blood Reviews|January 17, 2012
CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?Tali Siegal, Neta GoldschmidtCancer|September 16, 2003
High incidence of thromboembolism in patients with central nervous system lymphomaNeta Goldschmidt, Eduard Linetsky, Edna Shalom, et al.Oncotarget|November 22, 2017
MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphomaNir Pillar, Osnat Bairey, Neta Goldschmidt, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 15, 2014
Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteriaTali SiegalAdvances and Technical Standards in Neurosurgery|October 29, 2015
Clinical Relevance of Prognostic and Predictive Molecular Markers in GliomasTali SiegalNeuro-Oncology|March 19, 2013
Which drug or drug delivery system can change clinical practice for brain tumor therapy?Tali SiegalCurrent Oncology Reports|December 21, 2002
Toxicity of treatment for neoplastic meningitisTali SiegalJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 24, 2014
Clinical impact of molecular biomarkers in gliomasTali SiegalHematological Oncology|July 5, 2023
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtimeOsnat Bairey, Eyal Lebel, Chen Buxbaum, et al.Blood Reviews|March 20, 2018
The possible role of maintenance treatment for primary central nervous system lymphomaOsnat Bairey, Tali SiegalPageof 15